← All trials
NCT04746183
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 3, 2020
- Primary completion
- Nov 18, 2021
- Completion date
- Apr 30, 2022
- First posted
- Feb 9, 2021
- Last posted
- Aug 25, 2021
- Enrollment
- 600
- Arms / groups
- 9 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of LiverpoolLead sponsor
- University of LiverpoolCollaborator
- Moorgreen Hospital, SouthamptonCollaborator
- University of LiverpoolOverall official - principal investigator
- University of CambridgeCollaborator
- Royal Liverpool & Broadgreen University Hospitals NHS TrutsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.